Research memoCME Group Inc. (CME) · NASDAQMemo of October 22, 2026

CME Group stock forecast 2027–2029

MyStockButler's October 2026 analysis: CME Group's probability-weighted price is $304.16 by October 2027. It hinges on turning trading activity into durable fees and cash while defending liquidity and executing cloud and Treasury-clearing plans.

295.79
Share price today, USD
320.15 (+19%)
Weighted scenario, October 2029
3.9%
Real free cash flow yield
22.7x
P/E, next 12 months
Read the full CME Group memoYour first S&P 500 report is free · no card
Every number traced to CME Group's filings8 chapters · 18,747 words258 sources cited

Where could CME Group's shares be by October 2029?

The probability-weighted price is $304.16 by October 2027, a 6% total return including dividends. By October 2028, it reaches $309.90, a 12% return. By October 2029, it reaches $320.15, a 19% return.

The October 2029 range is $195.09 to $491.18. Today's price is $295.79. The base case is the most likely path, but the wide range reflects CME's exposure to trading activity, fee mix, execution and valuation.

Share price in October 2029: our three scenarios (USD)Today 295.79195.09Bear · 25% · -27%314.80Base · 55% · +18%491.18Bull · 20% · +80%
What the shares could be worthUSD per share at each date; in brackets the return since today's 295.79, dividends included
CaseProbabilityOctober 2027October 2028October 2029
Bear25%235.11 (-18%)206.93 (-25%)195.09 (-27%)
Base55%313.42 (+10%)314.69 (+14%)314.80 (+18%)
Bull20%365.03 (+27%)425.43 (+53%)491.18 (+80%)
Weighted100%304.16 (+6%)309.90 (+12%)320.15 (+19%)

What has to go right or wrong for CME Group?

Earnings drive the forecast. The base case uses $4,662 million in October 2027 and $4,851 million in October 2028. It reaches $5,040 million in October 2029. The bear case falls from $4,218 million to $4,104 million, as activity cools, lower-fee products weaken revenue per contract and cloud costs arrive early. The bull case rises from $4,800 million to $5,874 million, requiring sustained rates activity, Treasury clearing, data growth and cloud savings.

The view would move toward the bear case during 2027–2029 if interest-rate ADV and revenue per contract weaken as markets calm. Slow Securities Clearing adoption, persistent cloud costs or easing data growth would reduce earnings and cash available for buybacks.

How much cash does CME Group really make?

CME generated $4,277.1 million of operating cash in 2025 and spent $83.5 million on capital assets. That left $4,193.6 million of free cash flow, a high conversion rate for a business that does not need factories to expand.

Follow the money: real free cash flowUS$ millions
20252024202320222021
Cash from operations4,277.13,690.53,453.83,056.02,402.4
− Capital spending83.594.076.489.7127.2
= Free cash flow4,193.63,596.53,377.42,966.32,275.2
− Stock pay94.889.582.984.375.2
= Real free cash flow4,098.83,507.03,294.52,882.02,200.0

What this means. Stock pay uses no cash today, but it gives employees part of the company, so we subtract its value to show what is truly left for shareholders.

What does an investor pay for CME Group today?

What an investor pays todayUS$ millions
Today (Oct 22, 2026)
Share price295.79
Market value (calculated)106,360.0
P/E, last 12 months (calculated)24.3x
P/E, next 12 months (calculated)22.7x
Free cash flow yield (calculated)3.9%
Real free cash flow yield (calculated)3.9%

What this means. The market value uses an older share count, so it may be slightly too high because the company later bought back shares.

From the full memo · 1. The business

CME Group runs marketplaces where people trade changes in prices, and a clearing house that makes sure those trades are honored. It sells the machinery for managing risk: contracts, execution, clearing, data and access.

Continue reading, free
Your first S&P 500 report is free · no card

Where these numbers come from

More on CME Group

CME Group dividendAuf Deutsch

Its rivals

Deutsche Börse (DB1.DE)LSEG (LSEG.L)HKEX (0388.HK)

Browse

All stocksS&P 500 companiesCompanies C
The full CME Group memoYour first S&P 500 report is free
Read it